A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

NCT01481701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Carcinoma
Relapse

Interventions

DRUG: Oxaliplatin
DRUG: oxaliplatin

Sponsor

Jules Bordet Institute